KR102501636B9 - Tablet for oral administration comprising fenofibric acid and method for manufacturing same - Google Patents
Tablet for oral administration comprising fenofibric acid and method for manufacturing sameInfo
- Publication number
- KR102501636B9 KR102501636B9 KR1020210173686A KR20210173686A KR102501636B9 KR 102501636 B9 KR102501636 B9 KR 102501636B9 KR 1020210173686 A KR1020210173686 A KR 1020210173686A KR 20210173686 A KR20210173686 A KR 20210173686A KR 102501636 B9 KR102501636 B9 KR 102501636B9
- Authority
- KR
- South Korea
- Prior art keywords
- tablet
- oral administration
- manufacturing same
- fenofibric acid
- fenofibric
- Prior art date
Links
- MQOBSOSZFYZQOK-UHFFFAOYSA-N fenofibric acid Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1C(=O)C1=CC=C(Cl)C=C1 MQOBSOSZFYZQOK-UHFFFAOYSA-N 0.000 title 1
- 229960000701 fenofibric acid Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210173686A KR102501636B1 (en) | 2021-12-07 | 2021-12-07 | Tablet for oral administration comprising fenofibric acid and method for manufacturing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210173686A KR102501636B1 (en) | 2021-12-07 | 2021-12-07 | Tablet for oral administration comprising fenofibric acid and method for manufacturing same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR102501636B1 KR102501636B1 (en) | 2023-02-21 |
KR102501636B9 true KR102501636B9 (en) | 2024-03-13 |
Family
ID=85328488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210173686A KR102501636B1 (en) | 2021-12-07 | 2021-12-07 | Tablet for oral administration comprising fenofibric acid and method for manufacturing same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102501636B1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003013607A1 (en) * | 2001-08-07 | 2003-02-20 | Galephar M/F | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR |
BRPI0415121A (en) * | 2003-10-10 | 2006-11-28 | Lifecycle Pharma As | particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form |
EA200701751A1 (en) | 2005-03-30 | 2008-04-28 | Тева Фармасьютикал Индастриес Лтд. | IMPROVED PHENOPHIBRATE COMPOSITIONS |
UA100966C2 (en) * | 2005-04-08 | 2013-02-25 | Эбботт Леборетриз | Oral pharmaceutical formulation based on 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid |
KR20110097168A (en) * | 2010-02-24 | 2011-08-31 | 근화제약주식회사 | New pharmaceutical composition for treatment of hyperlipidemia |
KR101202994B1 (en) * | 2010-04-12 | 2012-11-21 | 한미사이언스 주식회사 | Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
KR101925590B1 (en) * | 2016-08-30 | 2018-12-05 | 대원제약 주식회사 | Formulation of fenofibric acid with improved bioavailability |
-
2021
- 2021-12-07 KR KR1020210173686A patent/KR102501636B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR102501636B1 (en) | 2023-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20192119T1 (en) | Composition and method for aiding sleep | |
PT2588090T (en) | Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts | |
MX2016004487A (en) | Enteric soft capsules comprising polyunsaturated fatty acids. | |
SG10201506708UA (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
ZA202105976B (en) | Pharmaceutical dosage form for application to mucous membranes and methods for producing same | |
EP3981400A4 (en) | Oral capsule and preparation method therefor | |
SG10201901677YA (en) | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis | |
PL3793534T3 (en) | An oral tablet for delivery of active ingredients to the gastrointestinal tract | |
SI3003383T1 (en) | Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d | |
SI2654729T1 (en) | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid | |
KR102501636B9 (en) | Tablet for oral administration comprising fenofibric acid and method for manufacturing same | |
WO2010081722A3 (en) | Orally disintegrating tablets for the treatment of pain | |
EP3485876A4 (en) | Oral pharmaceutical composition and method for producing particulate formulation comprising composition | |
EP3960240A4 (en) | Pharmaceutical preparation and method for producing same | |
GB201910294D0 (en) | Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate | |
WO2015166419A3 (en) | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain | |
ZA202110948B (en) | Pharmaceutical dosage forms and methods for their production | |
EP4117460C0 (en) | Chewable product for oral delivery of a substance, and method of manufacturing the same | |
ZA202109079B (en) | Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereof | |
EP3969002A4 (en) | Pharmaceutical composition of a weak acid drug and methods of administration | |
EP3941421A4 (en) | Pharmaceutical packaging system and method of manufacturing same | |
GB201512436D0 (en) | Method and production system for producing a pharmaceutical extrudate comprising a low-dose active pharmaceutical ingredient | |
EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form | |
MX2009001925A (en) | Oral pharmaceutical composition for use in respiratory diseases. | |
JP2017515858A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |